🇺🇸 FDA
Patent

US 10562941

Pneumolysin mutants and methods of use thereof

granted A61KA61K2039/55505A61K38/00

Quick answer

US patent 10562941 (Pneumolysin mutants and methods of use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/55505, A61K38/00, A61K39/00, A61K39/092